Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    August 2015
  1. WEISS SA, Hanniford D, Hernando E, Osman I, et al
    Revisiting determinants of prognosis in cutaneous melanoma.
    Cancer. 2015 Aug 26. doi: 10.1002/cncr.29634.
    PubMed     Text format     Abstract available


  2. BUCHBINDER EI, Sosman JA, Lawrence DP, McDermott DF, et al
    Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.
    Cancer. 2015 Aug 11. doi: 10.1002/cncr.29622.
    PubMed     Text format     Abstract available


    July 2015
  3. MENZIES AM, Wilmott JS, Drummond M, Lo S, et al
    Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.
    Cancer. 2015 Jul 28. doi: 10.1002/cncr.29586.
    PubMed     Text format     Abstract available


    June 2015
  4. PRINTZ C
    Coffee may lower risk of malignant melanoma.
    Cancer. 2015;121:1913.
    PubMed     Text format    


  5. LEHRER S
    Finasteride and dutasteride may reduce melanoma risk.
    Cancer. 2015 Jun 8. doi: 10.1002/cncr.29520.
    PubMed     Text format    


  6. LI WQ, Han J
    Reply to finasteride and dutasteride may reduce melanoma risk.
    Cancer. 2015 Jun 8. doi: 10.1002/cncr.29519.
    PubMed     Text format    


    May 2015
  7. ZHANG M, Qureshi AA, Fortner RT, Hankinson SE, et al
    Teenage acne and cancer risk in US women: A prospective cohort study.
    Cancer. 2015;121:1681-7.
    PubMed     Text format     Abstract available


    April 2015
  8. PRINTZ C
    Sun behaviors and genes may affect future melanoma risk.
    Cancer. 2015;121:1157.
    PubMed     Text format    


    March 2015
  9. BARTLETT EK, Simmons KD, Wachtel H, Roses RE, et al
    The rise in metastasectomy across cancer types over the past decade.
    Cancer. 2015;121:747-57.
    PubMed     Text format     Abstract available


    February 2015
  10. YAMAMOTO M, Fisher KJ, Wong JY, Koscso JM, et al
    Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Cancer. 2015 Feb 11. doi: 10.1002/cncr.29239.
    PubMed     Text format     Abstract available


    December 2014
  11. KOSARY CL, Altekruse SF, Ruhl J, Lee R, et al
    Clinical and prognostic factors for melanoma of the skin using SEER registries: Collaborative stage data collection system, version 1 and version 2.
    Cancer. 2014;120 Suppl S23:3807-3814.
    PubMed     Text format     Abstract available


  12. HUMPHRIS JL, Johns AL, Simpson SH, Cowley MJ, et al
    Clinical and pathologic features of familial pancreatic cancer.
    Cancer. 2014;120:3669-75.
    PubMed     Text format     Abstract available


    September 2014
  13. LEE SM, Moon J, Redman BG, Chidiac T, et al
    Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
    Cancer. 2014 Sep 23. doi: 10.1002/cncr.29055.
    PubMed     Text format     Abstract available


    August 2014
  14. FLEMING NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, et al
    Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
    Cancer. 2014 Aug 25. doi: 10.1002/cncr.28981.
    PubMed     Text format     Abstract available


  15. PRINTZ C
    Young people with non-melanoma skin cancers are at higher risk of other cancers.
    Cancer. 2014;120:2382-3.
    PubMed     Text format    


    July 2014
  16. LAUNAY-VACHER V, Zimner-Rapuch S, Poulalhon N, Fraisse T, et al
    Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients.
    Cancer. 2014;120:2158-63.
    PubMed     Text format     Abstract available


  17. CHAN MM, Haydu LE, Menzies AM, Azer MW, et al
    The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition.
    Cancer. 2014 Jul 1. doi: 10.1002/cncr.28851.
    PubMed     Text format     Abstract available


    May 2014
  18. TISHLER RB
    Increased clarity on the use of radiotherapy in the management of desmoplastic melanoma.
    Cancer. 2014;120:1315-8.
    PubMed     Text format    


    March 2014
  19. HAMID O, Ilaria R Jr, Garbe C, Wolter P, et al
    A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.
    Cancer. 2014 Mar 26. doi: 10.1002/cncr.28635.
    PubMed     Text format     Abstract available


    February 2014
  20. ASCIERTO PA, Margolin K
    Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.
    Cancer. 2014 Feb 27. doi: 10.1002/cncr.28622.
    PubMed     Text format    


  21. ACKERMAN A, Klein O, McDermott DF, Wang W, et al
    Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.
    Cancer. 2014 Feb 27. doi: 10.1002/cncr.28620.
    PubMed     Text format     Abstract available


  22. AZER MW, Menzies AM, Haydu LE, Kefford RF, et al
    Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.
    Cancer. 2014;120:530-6.
    PubMed     Text format     Abstract available


    January 2014
  23. TSENG J, Citrin DE, Waldman M, White DE, et al
    Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
    Cancer. 2014 Jan 28. doi: 10.1002/cncr.28547.
    PubMed     Text format     Abstract available


  24. PRINTZ C
    Consensus statement released for treating melanoma patients with immunotherapy.
    Cancer. 2014;120:3.
    PubMed     Text format    


    December 2013
  25. AGARWALA SS, Eggermont AM, O'Day S, Zager JS, et al
    Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
    Cancer. 2013 Dec 2. doi: 10.1002/cncr.28480.
    PubMed     Text format     Abstract available


    October 2013
  26. GUADAGNOLO BA , Prieto V, Weber R, Ross MI, et al
    The role of adjuvant radiotherapy in the local management of desmoplastic melanoma.
    Cancer. 2013 Oct 18. doi: 10.1002/cncr.28415.
    PubMed     Text format     Abstract available


  27. STROM T , Caudell JJ, Han D, Zager JS, et al
    Radiotherapy influences local control in patients with desmoplastic melanoma.
    Cancer. 2013 Oct 18. doi: 10.1002/cncr.28412.
    PubMed     Text format     Abstract available


    September 2013
  28. COIT DG , Ernstoff MS, Busam KJ
    Is pediatric melanoma always malignant?
    Cancer. 2013 Sep 10. doi: 10.1002/cncr.28291.
    PubMed     Text format    


  29. AVERBOOK BJ , Lee SJ, Delman KA, Gow KW, et al
    Pediatric melanoma: Analysis of an international registry.
    Cancer. 2013 Sep 10. doi: 10.1002/cncr.28289.
    PubMed     Text format     Abstract available


  30. PRINTZ C
    Highlights from the ASCO annual meeting.
    Cancer. 2013;119:3104-5.
    PubMed     Text format    


    August 2013
  31. BUCHEIT AD , Syklawer E, Jakob JA, Bassett RL Jr, et al
    Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
    Cancer. 2013 Aug 6. doi: 10.1002/cncr.28306.
    PubMed     Text format     Abstract available


  32. PILOWSKY PM
    Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
    Cancer. 2013 Aug 6. doi: 10.1002/cncr.28248.
    PubMed     Text format    


  33. TANG JY , Kubo J, Desai M
    Reply to aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
    Cancer. 2013 Aug 6. doi: 10.1002/cncr.28247.
    PubMed     Text format    


  34. LUKE JJ , Callahan MK, Postow MA, Romano E, et al
    Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
    Cancer. 2013 Aug 2. doi: 10.1002/cncr.28282.
    PubMed     Text format     Abstract available


    July 2013
  35. PRINTZ C
    Physicians Differ on the Use of Sentinel Lymph Node Biopsy for Melanoma: Published data receive various interpretations.
    Cancer. 2013;119:2515-6.
    PubMed     Text format    


  36. PRINTZ C
    Target: melanoma: Skin cancer screenings hold promise to reduce mortality rates, but usage of widespread screening lags.
    Cancer. 2013;119:2359-60.
    PubMed     Text format    


    May 2013
  37. HAMILTON R , Krauze M, Romkes M, Omolo B, et al
    Pathologic and gene expression features of metastatic melanomas to the brain.
    Cancer. 2013 May 21. doi: 10.1002/cncr.28029.
    PubMed     Text format     Abstract available


  38. HU CY , Xing Y, Cormier JN, Chang GJ, et al
    Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
    Cancer. 2013;119:1900-7.
    PubMed     Text format     Abstract available


    March 2013
  39. PRINTZ C
    New research on melanoma risk in red-haired people.
    Cancer. 2013;119:1118.
    PubMed     Text format    


  40. GAMBA CA , Swetter SM, Stefanick ML, Kubo J, et al
    Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
    Cancer. 2013 Mar 11. doi: 10.1002/cncr.27817.
    PubMed     Text format     Abstract available


    February 2013
  41. BAGARIA SP , Ray PS, Joseph RW, Heckman MG, et al
    Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Cancer. 2013 Feb 13. doi: 10.1002/cncr.27985.
    PubMed     Text format     Abstract available


  42. WEBER JS , Dummer R, de Pril V, Lebbe C, et al
    Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma.
    Cancer. 2013 Feb 7. doi: 10.1002/cncr.27969.
    PubMed     Text format     Abstract available


    December 2012
  43. BEASLEY GM , Sharma K, Wong J, Miller M, et al
    A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
    Cancer. 2012;118:6136-43.
    PubMed     Text format     Abstract available


  44. PRINTZ C
    Strides in personalized medicine.
    Cancer. 2012;118:5722-3.
    PubMed     Text format    


    September 2012
  45. PATEL SP , Lazar AJ, Papadopoulos NE, Liu P, et al
    Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
    Cancer. 2012 Sep 12. doi: 10.1002/cncr.27790.
    PubMed     Text format     Abstract available


  46. PRINTZ C
    Genetic test predicts whether eye cancer will spread.
    Cancer. 2012;118:4096.
    PubMed     Text format    


    August 2012
  47. KOTTSCHADE LA , Suman VJ, Perez DG, McWilliams RR, et al
    A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N0775.
    Cancer. 2012 Aug 22. doi: 10.1002/cncr.27760.
    PubMed     Text format     Abstract available


  48. KIM KB
    Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
    Cancer. 2012 Aug 22. doi: 10.1002/cncr.27756.
    PubMed     Text format    


    June 2012
  49. MURALI R , Brown PT, Kefford RF, Scolyer RA, et al
    Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma.
    Cancer. 2012 Jun 26. doi: 10.1002/cncr.27693.
    PubMed     Text format     Abstract available


  50. PRINTZ C
    Declines in melanoma deaths occur in most-educated individuals.
    Cancer. 2012;118:3001.
    PubMed     Text format    


    May 2012
  51. JOHANNESDOTTIR SA , Chang ET, Mehnert F, Schmidt M, et al
    Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: A population-based case-control study.
    Cancer. 2012 May 29. doi: 10.1002/cncr.27406.
    PubMed     Text format     Abstract available


  52. CURIEL-LEWANDROWSKI C , Swetter SM, Einspahr JG, Hsu CH, et al
    Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: Evaluation of potential chemopreventive activity.
    Cancer. 2012 May 17. doi: 10.1002/cncr.27540.
    PubMed     Text format     Abstract available


  53. MU E , Lange JR, Strouse JJ
    Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma.
    Cancer. 2012;118:2700-7.
    PubMed     Text format     Abstract available


    April 2012
  54. KATALINIC A , Waldmann A, Weinstock MA, Geller AC, et al
    Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening.
    Cancer. 2012 Apr 19. doi: 10.1002/cncr.27566.
    PubMed     Text format     Abstract available


    March 2012
  55. JAGTAP D , Rosenberg CA, Martin LW, Pettinger M, et al
    Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
    Cancer. 2012 Mar 20. doi: 10.1002/cncr.27497.
    PubMed     Text format     Abstract available


    January 2012
  56. HWA C , Price LS, Belitskaya-Levy I, Ma MW, et al
    Single versus multiple primary melanomas: Old questions and new answers.
    Cancer. 2012 Jan 13. doi: 10.1002/cncr.27407.
    PubMed     Text format     Abstract available


    December 2011
  57. JAKOB JA , Bassett RL Jr, Ng CS, Curry JL, et al
    NRAS mutation status is an independent prognostic factor in metastatic melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26724.
    PubMed     Text format     Abstract available


  58. SWETTER SM , Pollitt RA, Johnson TM, Brooks DR, et al
    Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26707.
    PubMed     Text format     Abstract available


  59. POLLITT RA , Swetter SM, Johnson TM, Patil P, et al
    Examining the pathways linking lower socioeconomic status and advanced melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26706.
    PubMed     Text format     Abstract available


    October 2011
  60. PRINTZ C
    Duke University researchers develop laser-based tool for melanoma.
    Cancer. 2011;117:4338-9.
    PubMed     Text format    


    September 2011
  61. JENSEN TO , Schmidt H, Moller HJ, Donskov F, et al
    Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Cancer. 2011 Sep 22. doi: 10.1002/cncr.26511.
    PubMed     Text format     Abstract available


    July 2011
  62. ERMAN AB , Collar RM, Griffith KA, Lowe L, et al
    Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Cancer. 2011 Jul 19. doi: 10.1002/cncr.26288.
    PubMed     Text format     Abstract available


    June 2011
  63. ZHANG Z , Chen G, Cheng Y, Martinka M, et al
    Prognostic significance of RUNX3 expression in human melanoma.
    Cancer. 2011;117:2719-27.
    PubMed     Text format     Abstract available


    May 2011
  64. KLUGER HM , Dudek AZ, McCann C, Ritacco J, et al
    A phase 2 trial of dasatinib in advanced melanoma.
    Cancer. 2011;117:2202-8.
    PubMed     Text format    


  65. GADIOT J , Hooijkaas AI, Kaiser AD, van Tinteren H, et al
    Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Cancer. 2011;117:2192-201.
    PubMed     Text format    


  66. MCLAUGHLIN JM , Fisher JL, Paskett ED
    Marital status and stage at diagnosis of cutaneous melanoma: Results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.
    Cancer. 2011;117:1984-93.
    PubMed     Text format     Abstract available


    April 2011
  67. ZAKRZEWSKI J , Geraghty LN, Rose AE, Christos PJ, et al
    Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Cancer. 2011;117:1711-20.
    PubMed     Text format     Abstract available


  68. KOTTSCHADE LA , Suman VJ, Amatruda T 3rd, McWilliams RR, et al
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E(1).
    Cancer. 2011;117:1704-10.
    PubMed     Text format     Abstract available


  69. EIGENTLER TK , Figl A, Krex D, Mohr P, et al
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Cancer. 2011;117:1697-1703.
    PubMed     Text format     Abstract available


  70. OTHUS M , Moon J, Margolin K
    Melanoma's deadly march to the brain: By what route, and can it be stopped?
    Cancer. 2011;117:1560-3.
    PubMed     Text format    


    March 2011
  71. KIRKWOOD JM , Gonzalez R, Reintgen D, Clingan PR, et al
    A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26068.
    PubMed     Text format     Abstract available


  72. SOSMAN JA , Moon J, Tuthill RJ, Warneke JA, et al
    A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26111.
    PubMed     Text format     Abstract available


  73. OLLILA DW
    A phase 2 trial of complete resection for stage IV melanoma : Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26118.
    PubMed     Text format    


  74. KELLY P , Zagars GK, Cormier JN, Ross MI, et al
    Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26088.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: